GPP-100 set its footprint on Scandinavian Peninsula

GPP-100, Goldsite’s eye-catcher innovative specific protein product, starts its journey to Sweden in December 2019. Since it was launched in 2018, GPP-100 has been installed in many countries i.e. India, Philippine, Qatar, SA, Romania etc. Its excellent and stable performance has impressed clients from all over the world. 

GPP-100 is designed for multiple application scenarios like GPs (General Practice), clinics & Small or medium labs. All tests are measured with disposable, ready-to-use cartridges, and are easily performed by non-technical personnel. 

GPP-100 is a compact analyzer with full range test menu, covering categories of diabetes, immune disease, rheumatoid disease, cardiovascular disease, inflammation and kidney disease. 

For HbA1c, GPP-100 uses capillary sample. Capillary sampling is easily performed by staff members, eliminating the need for venipunctures, trained phlebotomists, and bold drawing tubes and needles. GPP-100’s use of a small, 5uL blood drop makes testing virtually painless for the patient.

Given all the above advantages, GPP-100 would be an ideal solution for GP’s house, small labs and clinics in Sweden. 

Goldsite’s brand is globally synonymous with quality. Our ISO-certified and CFDA licensed, state-of-the-art GMP manufacturing facilities and experienced personnel enable us to stay at the forefront of this industry. Goldsite Diagnostics Inc. will always dedicated to fulfil our commitment. Together with our talented staff, we devote to developing and manufacturing high quality diagnostics assays to serve the needs of the global community.